Mutabilis SA
http://www.mutabilis.fr
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Mutabilis SA
FAB Pharma raises series A to fund former Mutabilis programme
FAB Pharma, a corporate spin-out from the former French biotechnology company Mutabilis, has raised a series A round of €2.3 million led by the French venture capital firms CDC Innovation and Bioam Gestion. The US-based hedge fund Redmile Group also participated.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice